Jeffrey D Greenberg

Jeffrey D Greenberg

UNVERIFIED PROFILE

Are you Jeffrey D Greenberg?   Register this Author

Register author
Jeffrey D Greenberg

Jeffrey D Greenberg

Publications by authors named "Jeffrey D Greenberg"

Are you Jeffrey D Greenberg?   Register this Author

100Publications

3404Reads

28Profile Views

Long-term, Real-world Safety of Adalimumab in Rheumatoid Arthritis: Analysis of a Prospective US-Based Registry.

J Rheumatol 2019 Aug 1. Epub 2019 Aug 1.

From the University of Massachusetts Medical School, Worcester, MA, USA; Corrona, LLC, Waltham, MA, USA; AbbVie, North Chicago, IL, USA; New York University School of Medicine, New York, NY, USA. This study is sponsored by Corrona, LLC. Corrona, LLC has been supported through contracted subscriptions in the last 2 years by AbbVie, Amgen, Boehringer Ingelheim, Bristol-Myers Squibb, Crescendo, Eli Lilly and Company, Genentech, Gilead, GSK, Horizon Pharma USA, Janssen, Momenta Pharmaceuticals, Novartis, Pfizer Inc, Roche, Merck, UCB and Valeant. Financial support for the study was provided by AbbVie. The study design and conduct were a collaboration between Corrona and AbbVie. AbbVie participated in the interpretation of data, review and approval of the manuscript. LR Harrold is an employee and shareholder of Corrona, LLC. She has been a consultant to AbbVie, BMS, and Roche and has a research grant from Pfizer. CJ Barr is an employee and shareholder of Corrona, LLC. HJ Litman is an employee of Corrona, LLC. B Gershenson is an employee of University of Massachusetts Medical School. J Griffith, SS Islam, D Guo, J Fay, and P Zueger are employees of AbbVie Inc. and own AbbVie stock. J Greenberg is an employee and shareholder of Corrona, LLC. He has been a consultant to Genentech, Janssen, Novartis, Pfizer and Eli Lilly.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.190260DOI Listing
August 2019

US real-world effectiveness of secukinumab for the treatment of psoriasis: 6-month analysis from the Corrona Psoriasis Registry.

J Dermatolog Treat 2019 Apr 29:1-9. Epub 2019 Apr 29.

f Department of Dermatology , Icahn School of Medicine at Mount Sinai , New York , NY , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/09546634.2019.1603361DOI Listing
April 2019

Characterization of Patients With Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis in the US-Based Corrona Registry.

Arthritis Care Res (Hoboken) 2018 11 8;70(11):1661-1670. Epub 2018 Oct 8.

Corrona, LLC, Southborough, Massachusetts and New York University School of Medicine, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acr.23534DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282817PMC
November 2018

Evaluation of a Methodologic Approach to Define an Inception Cohort of Rheumatoid Arthritis Patients Using Administrative Data.

Arthritis Care Res (Hoboken) 2018 10 4;70(10):1541-1545. Epub 2018 Sep 4.

University of Alabama at Birmingham.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acr.23533DOI Listing
October 2018

Influence of Axial Involvement on Clinical Characteristics of Psoriatic Arthritis: Analysis from the Corrona Psoriatic Arthritis/Spondyloarthritis Registry.

J Rheumatol 2018 10 1;45(10):1389-1396. Epub 2018 Jul 1.

From the Swedish Medical Center and University of Washington, Seattle, Washington; Novartis Pharmaceuticals Corp., East Hanover, New Jersey; Corrona LLC, Waltham, Massachusetts; University of California San Diego, La Jolla, California; Allergy, Immunology and Rheumatology Division, University of Rochester Medical Center, Rochester; New York University School of Medicine, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.171094DOI Listing
October 2018

Influence of obesity, age, and comorbidities on the multi-biomarker disease activity test in rheumatoid arthritis.

Semin Arthritis Rheum 2018 02 2;47(4):472-477. Epub 2017 Aug 2.

Corrona Research Foundation, Albany, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semarthrit.2017.07.010DOI Listing
February 2018

Characterization of disease burden, comorbidities, and treatment use in a large, US-based cohort: Results from the Corrona Psoriasis Registry.

J Am Acad Dermatol 2018 02 16;78(2):323-332. Epub 2017 Oct 16.

Icahn School of Medicine at Mount Sinai, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2017.10.012DOI Listing
February 2018

Design characteristics of the Corrona Japan rheumatoid arthritis registry.

Mod Rheumatol 2018 Jan 27;28(1):95-100. Epub 2017 Apr 27.

g The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health , Kitakyushu , Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14397595.2017.1317383DOI Listing
January 2018

Rebound in Measures of Disease Activity and Symptoms in Corrona Registry Patients with Psoriatic Arthritis Who Discontinue Tumor Necrosis Factor Inhibitor Therapy after Achieving Low Disease Activity.

J Rheumatol 2018 01 1;45(1):78-82. Epub 2017 Oct 1.

From Corrona LLC, Southborough; Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts; Amgen Inc., Thousand Oaks, California; Wade Outcomes Research and Consulting, Salt Lake City, Utah; New York University School of Medicine, New York, New York; Department of Epidemiology, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.161567DOI Listing
January 2018

Clinical and Patient-reported Outcomes in Patients with Psoriatic Arthritis (PsA) by Body Surface Area Affected by Psoriasis: Results from the Corrona PsA/Spondyloarthritis Registry.

J Rheumatol 2017 08 15;44(8):1151-1158. Epub 2017 Jun 15.

From the Swedish Medical Center and University of Washington (UW) Medicine, Seattle, Washington; Corrona LLC, Southborough, Massachusetts; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey; The University of Texas MD Anderson Cancer Center, Houston, Texas; University of California (UC) at San Diego, La Jolla, California; University of Rochester Medical Center, Rochester; New York University (NYU) School of Medicine, New York, New York; Scott and White Health Plan, Temple, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.160963DOI Listing
August 2017

How comparable are rates of malignancies in patients with rheumatoid arthritis across the world? A comparison of cancer rates, and means to optimise their comparability, in five RA registries.

Ann Rheum Dis 2016 Oct 30;75(10):1789-96. Epub 2015 Nov 30.

Arthritis Research UK Centre for Epidemiology, The University of Manchester, Manchester, UK NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2015-208105DOI Listing
October 2016

Agreement between Rheumatologist and Patient-reported Adherence to Methotrexate in a US Rheumatoid Arthritis Registry.

J Rheumatol 2016 06 1;43(6):1027-9. Epub 2016 May 1.

From the University of Alabama at Birmingham, Birmingham, Alabama; Consortium of Rheumatology Researchers of North America (CORRONA) LLC, Southborough; University of Massachusetts, Worcester, Massachusetts, USA.J.R. Curtis, MD, MS, MPH, University of Alabama at Birmingham; A. Bharat, MD, MPH, University of Alabama at Birmingham; L. Chen, PhD, University of Alabama at Birmingham; J.D. Greenberg, MD, MPH, CORRONA LLC; L. Harrold, MD, MPH, University of Massachusetts; J.M. Kremer, MD, CORRONA LLC; T. Sommers, MS, CORRONA LLC; D. Pappas, MD, MPH, CORRONA LLC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.151136DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891269PMC
June 2016

TYK2 protein-coding variants protect against rheumatoid arthritis and autoimmunity, with no evidence of major pleiotropic effects on non-autoimmune complex traits.

PLoS One 2015 7;10(4):e0122271. Epub 2015 Apr 7.

Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America; Division of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America; Program in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0122271PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4388675PMC
March 2016

Healthcare Resource Use and Direct Costs in Patients with Ankylosing Spondylitis and Psoriatic Arthritis in a Large US Cohort.

J Rheumatol 2016 Jan 1;43(1):88-96. Epub 2015 Dec 1.

From the Department of Rheumatology, New York University School of Medicine, New York, New York; Health Economics and Outcomes Research, and Outcomes Research Methods and Analytics, US Health Economics and Outcomes Research, Novartis Pharmaceuticals Corp., East Hanover; KMK Consulting Inc., Florham Park, New Jersey; Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, Maryland, USA.J.D. Greenberg, MD, MPH, New York University Hospital for Joint Disease, and Department of Rheumatology, New York University School of Medicine; J.B. Palmer, PharmD, Health Economics and Outcomes Research, Novartis; Y. Li, PhD, Outcomes Research Methods and Analytics, US Health Economics & Outcomes Research, Novartis; V. Herrera, PharmD, Health Economics and Outcomes Research, Novartis; Y. Tsang, PharmD, Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy; M. Liao, MA, KMK Consulting Inc.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.150540DOI Listing
January 2016

Comparative effectiveness of biologic monotherapy versus combination therapy for patients with psoriatic arthritis: results from the Corrona registry.

RMD Open 2015 30;1(1):e000181. Epub 2015 Dec 30.

Epidemiology and Outcomes Research, Corrona, LLC, Southborough, Massachusetts, USA; Division of Rheumatology, New York University School of Medicine, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/rmdopen-2015-000181DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4716450PMC
January 2016

Incidence and Predictors of Biological Antirheumatic Drug Discontinuation Attempts among Patients with Rheumatoid Arthritis in Remission: A CORRONA and NinJa Collaborative Cohort Study.

J Rheumatol 2015 Dec 1;42(12):2238-46. Epub 2015 Nov 1.

From the Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston; University of Massachusetts Medical School, Worcester, Massachusetts; New York University Hospital for Joint Diseases, New York; Albany Medical College, Center for Rheumatology, Albany, New York; Division of Rheumatology, Allergy and Immunology, University of California San Diego, La Jolla, California, USA; Department of Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Immuno-Rheumatology Center, St. Luke's International Hospital, Tokyo; Department of Rheumatology, Kameda Medical Center, Kamogawa; Department of Clinical Research, National Hospital Organization Osaka Minami Medical Center, Kawachinagano, Osaka; Department of Rheumatology, Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, Sagamihara, Japan.K. Yoshida, MD, MPH, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, and Department of Epidemiology, Harvard T.H. Chan School of Public Health; H. Radner, MD, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, and Department of Internal Medicine III, Division of Rheumatology, Medical University of Vienna; M.D. Mjaavatten, MD, PhD, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, and Department of Rheumatology, Diakonhjemmet Hospital; J.D. Greenberg, MD, MPH, New York University Hospital for Joint Diseases; A. Kavanaugh, MD, Division of Rheumatology, Allergy and Immunology, University of California San Diego; M. Kishimoto, MD, PhD, Immuno-Rheumatology Center, St. Luke's International Hospital; K. Matsui, MD, Department of Rheumatology, Kameda Medical Center; M. Okada, MD, Immuno-Rheumatology Center, St. Luke's International Hospital; G. Reed, PhD, University of Massa

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.150240DOI Listing
December 2015

New data and an old puzzle: the negative association between schizophrenia and rheumatoid arthritis.

Authors:
S Hong Lee Enda M Byrne Christina M Hultman Anna Kähler Anna A E Vinkhuyzen Stephan Ripke Ole A Andreassen Thomas Frisell Alexander Gusev Xinli Hu Robert Karlsson Vasilis X Mantzioris John J McGrath Divya Mehta Eli A Stahl Qiongyi Zhao Kenneth S Kendler Patrick F Sullivan Alkes L Price Michael O'Donovan Yukinori Okada Bryan J Mowry Soumya Raychaudhuri Naomi R Wray William Byerley Wiepke Cahn Rita M Cantor Sven Cichon Paul Cormican David Curtis Srdjan Djurovic Valentina Escott-Price Pablo V Gejman Lyudmila Georgieva Ina Giegling Thomas F Hansen Andrés Ingason Yunjung Kim Bettina Konte Phil H Lee Andrew McIntosh Andrew McQuillin Derek W Morris Markus M Nöthen Colm O'Dushlaine Ann Olincy Line Olsen Carlos N Pato Michele T Pato Benjamin S Pickard Danielle Posthuma Henrik B Rasmussen Marcella Rietschel Dan Rujescu Thomas G Schulze Jeremy M Silverman Srinivasa Thirumalai Thomas Werge Ingrid Agartz Farooq Amin Maria H Azevedo Nicholas Bass Donald W Black Douglas H R Blackwood Richard Bruggeman Nancy G Buccola Khalid Choudhury Robert C Cloninger Aiden Corvin Nicholas Craddock Mark J Daly Susmita Datta Gary J Donohoe Jubao Duan Frank Dudbridge Ayman Fanous Robert Freedman Nelson B Freimer Marion Friedl Michael Gill Hugh Gurling Lieuwe De Haan Marian L Hamshere Annette M Hartmann Peter A Holmans René S Kahn Matthew C Keller Elaine Kenny George K Kirov Lydia Krabbendam Robert Krasucki Jacob Lawrence Todd Lencz Douglas F Levinson Jeffrey A Lieberman Dan-Yu Lin Don H Linszen Patrik K E Magnusson Wolfgang Maier Anil K Malhotra Manuel Mattheisen Morten Mattingsdal Steven A McCarroll Helena Medeiros Ingrid Melle Vihra Milanova Inez Myin-Germeys Benjamin M Neale Roel A Ophoff Michael J Owen Jonathan Pimm Shaun M Purcell Vinay Puri Digby J Quested Lizzy Rossin Douglas Ruderfer Alan R Sanders Jianxin Shi Pamela Sklar David St Clair T Scott Stroup Jim Van Os Peter M Visscher Durk Wiersma Stanley Zammit S Louis Bridges Hyon K Choi Marieke J H Coenen Niek de Vries Philippe Dieud Jeffrey D Greenberg Tom W J Huizinga Leonid Padyukov Katherine A Siminovitch Paul P Tak Jane Worthington Philip L De Jager Joshua C Denny Peter K Gregersen Lars Klareskog Xavier Mariette Robert M Plenge Mart van Laar Piet van Riel

Int J Epidemiol 2015 Oct;44(5):1706-21

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ije/dyv136DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881824PMC
October 2015

Effectiveness of Rituximab for the Treatment of Rheumatoid Arthritis in Patients with Prior Exposure to Anti-TNF: Results from the CORRONA Registry.

J Rheumatol 2015 Jul 1;42(7):1090-8. Epub 2015 May 1.

From the University of Massachusetts Medical School, Worcester; Corrona LLC, Southborough, Massachusetts; Genentech Inc., South San Francisco, California; Albany Medical College and The Center for Rheumatology, Albany; New York University (NYU) School of Medicine, New York, New York, USA.L.R. Harrold, MD, MPH, Department of Medicine, University of Massachusetts Medical School; G.W. Reed, PhD, Department of Medicine, University of Massachusetts Medical School, and Corrona LLC; A. Shewade, MS, Genentech Inc.; R. Magner, MPH, Department of Medicine, University of Massachusetts Medical School; K.C. Saunders, MS, Corrona LLC; A. John, BSN, MPH, Genentech Inc.; J.M. Kremer, MD, Department of Rheumatology, Albany Medical College, and The Center for Rheumatology; J.D. Greenberg, MD, MPH, Department of Medicine, Division of Rheumatology, NYU School of Medicine.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.141043DOI Listing
July 2015

Characteristics Associated with Biologic Monotherapy Use in Biologic-Naive Patients with Rheumatoid Arthritis in a US Registry Population.

Rheumatol Ther 2015 Jun 27;2(1):85-96. Epub 2015 Jan 27.

Albany Medical College and The Center for Rheumatology, 1367 Washington Ave, Suite 101, Albany, NY, 12206, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40744-015-0008-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4883255PMC
June 2015

Increased plasma IL-17F levels in rheumatoid arthritis patients are responsive to methotrexate, anti-TNF, and T cell costimulatory modulation.

Inflammation 2015 Feb;38(1):180-6

Department of Rheumatology, New York University Hospital for Joint Diseases, 301 East 17th Street, suite 1410, New York, NY, 10003, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10753-014-0020-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015768PMC
February 2015

A weighted genetic risk score using all known susceptibility variants to estimate rheumatoid arthritis risk.

Ann Rheum Dis 2015 Jan 3;74(1):170-6. Epub 2013 Oct 3.

Arthritis Research UK Epidemiology Unit, Centre for Musculoskeletal Research, Institute of Inflammation and Repair, The University of Manchester, Manchester, UK.

View Article

Download full-text PDF

Source
http://ard.bmj.com/lookup/doi/10.1136/annrheumdis-2013-20413
Publisher Site
http://dx.doi.org/10.1136/annrheumdis-2013-204133DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283663PMC
January 2015

Integration of sequence data from a Consanguineous family with genetic data from an outbred population identifies PLB1 as a candidate rheumatoid arthritis risk gene.

PLoS One 2014 10;9(2):e87645. Epub 2014 Feb 10.

Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America ; Division of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America ; Program in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0087645PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3919745PMC
October 2014

"Design characteristics of the CORRONA CERTAIN study: a comparative effectiveness study of biologic agents for rheumatoid arthritis patients".

BMC Musculoskelet Disord 2014 Apr 1;15:113. Epub 2014 Apr 1.

Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL 35294-7201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2474-15-113DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978136PMC
April 2014

Comparative cancer risk associated with methotrexate, other non-biologic and biologic disease-modifying anti-rheumatic drugs.

Semin Arthritis Rheum 2014 Feb 5;43(4):489-97. Epub 2013 Sep 5.

Clinical Trials Unit, Division of Rheumatology, New York University School of Medicine, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semarthrit.2013.08.003DOI Listing
February 2014

Genetics of rheumatoid arthritis contributes to biology and drug discovery.

Nature 2014 Feb 25;506(7488):376-81. Epub 2013 Dec 25.

1] Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA. [2] Division of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA. [3] Program in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts 02142, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature12873DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944098PMC
February 2014

Age-dependent ferritin elevations and HFE C282Y mutation as risk factors for symptomatic knee osteoarthritis in males: a longitudinal cohort study.

BMC Musculoskelet Disord 2014 Jan 8;15. Epub 2014 Jan 8.

Division of Rheumatology, Department of Medicine, New York University School of Medicine, NYU Hospital for Joint Diseases, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2474-15-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3893611PMC
January 2014

Patient perspectives on achieving treat-to-target goals: a critical examination of patient-reported outcomes.

Arthritis Care Res (Hoboken) 2013 Oct;65(10):1707-12

University of Alabama at, Birmingham.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acr.22048DOI Listing
October 2013

Predictors and persistence of new-onset clinical remission in rheumatoid arthritis patients.

Semin Arthritis Rheum 2013 Oct 3;43(2):137-43. Epub 2013 Jun 3.

Department of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, 510, 20th St. South, FOT 805D, Birmingham, AL 35294.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semarthrit.2013.02.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184191PMC
October 2013

Association of rheumatoid arthritis risk alleles with response to anti-TNF biologics: results from the CORRONA registry and meta-analysis.

Inflammation 2013 Apr;36(2):279-84

Division of Rheumatology, Department of Medicine, New York Presbyterian Hospital, College of Physicians and Surgeons, Columbia University, P&S Building, Suite 10-455, New York, NY 10032, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10753-012-9544-4DOI Listing
April 2013

Comparative effectiveness of nonbiologic versus biologic disease-modifying antirheumatic drugs for rheumatoid arthritis.

J Rheumatol 2013 Feb 15;40(2):127-36. Epub 2013 Jan 15.

Division of Rheumatology, James M. Anderson Center for Health Systems Excellence, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.120400DOI Listing
February 2013

Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout.

J Rheumatol 2012 Jul 1;39(7):1458-64. Epub 2012 Jun 1.

Crystal Diseases Study Group, Division of Rheumatology, New York University School of Medicine, New York, New York 10003, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.111533DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3733459PMC
July 2012

Smoking, smoking cessation, and disease activity in a large cohort of patients with rheumatoid arthritis.

J Rheumatol 2012 May 15;39(5):904-9. Epub 2012 Mar 15.

Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.110852DOI Listing
May 2012

Noninvasive cardiovascular imaging in rheumatoid arthritis: current modalities and the emerging role of magnetic resonance and positron emission tomography imaging.

Semin Arthritis Rheum 2012 Apr 13;41(5):676-88. Epub 2011 Oct 13.

Division of Rheumatology, New York University Hospital for Joint Diseases, New York, New York 10003, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semarthrit.2011.08.007DOI Listing
April 2012

Cardiovascular safety of biologic therapies for the treatment of RA.

Nat Rev Rheumatol 2011 Nov 15;8(1):13-21. Epub 2011 Nov 15.

Department of Rheumatology, New York University Hospital for Joint Diseases, 301 East 17th Street, Suite 1410, New York, NY 10003, USA. jeffrey.greenberg@ nyumc.org

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrrheum.2011.168DOI Listing
November 2011

High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis.

Ann Rheum Dis 2011 May 2;70(5):785-91. Epub 2011 Feb 2.

Division of Rheumatology, University of California Los Angeles, Los Angeles, CA 90095, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/ard.2010.128637DOI Listing
May 2011

Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis.

Ann Rheum Dis 2011 Apr 24;70(4):576-82. Epub 2010 Nov 24.

Department of Rheumatology, New York University Hospital for Joint Diseases, 301 East 17th Street, Suite 1410, New York, NY 10003, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/ard.2010.129916DOI Listing
April 2011

A modified rheumatoid arthritis disease activity score without acute-phase reactants (mDAS28) for epidemiological research.

J Rheumatol 2010 Aug 1;37(8):1607-14. Epub 2010 Jul 1.

Department of Medicine, Division of Preventive and Behavioral Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 01655, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.090831DOI Listing
August 2010

The role of microRNA in rheumatoid arthritis and other autoimmune diseases.

Clin Immunol 2010 Jul 12;136(1):1-15. Epub 2010 Mar 12.

Division of Rheumatology, Department of Medicine, NYU School of Medicine/NYU Hospital for Joint Diseases, New York, NY 10009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clim.2010.02.005DOI Listing
July 2010

Dendritic cells as targets for therapy in rheumatoid arthritis.

Nat Rev Rheumatol 2009 Oct;5(10):566-71

Cancer Institute, New York University Langone Medical Center, and New York University Hospital for Joint Diseases, New York, NY 10016, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/nrrheum.2009.185
Publisher Site
http://dx.doi.org/10.1038/nrrheum.2009.185DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2884969PMC
October 2009

Assessing infection risk with biologic agents in RA: methodological challenges.

Nat Rev Rheumatol 2009 05;5(5):288-91

New York University Hospital for Joint Diseases, New York, NY 10003, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrrheum.2009.51DOI Listing
May 2009